Logo

Mawi DNA Technologies ISWAB-Microbiome

Jan 25, 2017

Mawi DNA Technologies has launched the iSWAB-Microbiome, a biosampling tool designed to collect and stabilize microbial content and diversity within gut, rectal, vaginal, skin, oral, or soil samples for processing. The tool was developed to produce an accurate representation of the microbiota composition without loss of any taxa from the point of collection to processing, to provide researchers with the ability to analyze microbiome with minimal host gDNA contamination, and to enable analysis of the microbiome DNA and RNA from the same sample, the company said.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.